STOCK TITAN

Reliance Global Group Series A Warrants (EZRAW) 10-K Filings

EZRAW

Here are the 10-K annual reports from Reliance Global Group, Inc. Series A Warrants (EZRAW) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 10-K covers the audited annual report, with the full financial statements, so if you follow EZRAW and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full EZRAW filings page.

Rhea-AI Summary

Reliance Global Group, Inc. filed an amendment to its annual report for the year ended December 31, 2025 to correct the list of exhibits. The company had inadvertently omitted its Compensation Recovery Policy dated November 13, 2023, which is now added as Exhibit 97.1.

The amendment also includes current-dated CEO and CFO certifications under Section 302 of the Sarbanes-Oxley Act but makes no changes to the financial statements or other disclosures in the original report. As of March 10, 2026, the company had 21,253,013 common shares outstanding, and non-affiliate common stock held a market value of about $5.3 million as of June 30, 2025.

Rhea-AI Summary

Reliance Global Group, Inc., now trading as EZRA, describes a holding‑company model built on insurance agencies, InsurTech platforms, and new majority investments in technology businesses. Insurance operations remain the core, centered on the RELI Exchange B2B platform and 5MinuteInsure.com direct‑to‑consumer portal, both focused on multi‑carrier digital distribution.

The company outlines its new EZRA International Group and “Scale51” strategy, exemplified by a staged deal to acquire 51% of cybersecurity firm Enquantum and a non‑binding term sheet to take a majority stake in Israeli diagnostics company Scentech. It also details 2025 asset sales used to reduce Oak Street debt, adoption of a digital‑asset treasury policy, and a January 2026 public offering of about $2.0 million of common stock and warrants to fund working capital, strategic investments, and general purposes, alongside extensive risk factors covering financing needs, Nasdaq listing compliance, geopolitical exposure, cybersecurity, regulation, and execution of its acquisition‑driven growth plan.